33 C
New York
Thursday, June 11, 2026

Tag: data privacy

La Rosa Holdings Corp. Launches AI-Powered Communication Bot to Streamline Recruiting and Agent Support

Celebration, FL, July 15, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of its proprietary AI-powered communication bot built specifically to enhance agent recruiting and support operations across its platform.

Gainsight Expands Global Reach with New EU Datacenter

New regional datacenter strengthens Gainsight’s commitment to EMEA growth, enterprise readiness, and the global deployment of AI-powered customer intelligence
New regional datacenter strengthens Gainsight’s commitment to EMEA growth, enterprise readiness, and the global deployment of AI-powered customer intelligence

Virtual Lab Software Market to Reach USD 2817 Million by 2031 | Cloud-Based Labs Fuel Growth – Valuates Reports

BANGALORE, India, July 14, 2025 /PRNewswire/ -- Virtual Lab Software Market is Segmented by Type (On-Premise, Cloud-Based), by Application (Virtual Lab Software Market, Large...

Virtual Lab Software Market to Reach USD 2817 Million by 2031 | Cloud-Based Labs Fuel Growth – Valuates Reports

BANGALORE, India, July 14, 2025 /PRNewswire/ -- Virtual Lab Software Market is Segmented by Type (On-Premise, Cloud-Based), by Application (Virtual Lab Software Market, Large...

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Rockerbox Customers Whose Data May Have Been Compromised

The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Rockerbox.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised

Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Artivion, Inc.

HCLSoftware Launches Sovereign AI Aimed at Governments and Regulated Organizations Concerned with Their Data Privacy

NOIDA, India, July 10, 2025 /PRNewswire/ -- HCLSoftware, a global leader in enterprise software solutions, announced today the launch of HCL Domino 14.5. Specifically...

Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard of clinical trials SINGAPORE,...

Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard of clinical trials SINGAPORE,...

AI Models Promise Control—Until They Don’t

A new AI model, FlexOlmo, from the Allen Institute for AI, is stirring the pot. Unlike traditional models, it allows data owners to retain...

edYOU Applies AI to Deliver Personalized Learning for Every Student

LOS ANGELES, July 8, 2025 /PRNewswire/ -- The push toward more personalized instruction in K–12 classrooms is accelerating, and platforms like edYOU are helping...

BloodVitals Pulse Oximeter 2025 Release Reinforces Pain-Free, Real-Time Monitoring of Blood Vitals with Hospital-Grade Precision at Home

In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.
In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.

Cellebrite Names David Barter Chief Financial Officer

CFO Dana Gerner to Retire
CFO Dana Gerner to Retire

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

- A word from our sponsors -

spot_img
HomeTagsData privacy